BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Prognosis
524 results:

  • 1. Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis.
    Hu Z; Yang Y; Li J; Hu Z
    Hematology; 2024 Dec; 29(1):2346965. PubMed ID: 38687637
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical Characteristics and prognosis of Acute Myeloid leukemia Patients with
    Shan RQ; Huang S; Gu ZY; Wang N; Liu DH; Dou LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):327-334. PubMed ID: 38660832
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive Molecular Profiling of npm1-Mutated Acute Myeloid leukemia Using RNAseq Approach.
    Petiti J; Pignochino Y; Schiavon A; Giugliano E; Berrino E; Giordano G; Itri F; Dragani M; Cilloni D; Lo Iacono M
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612443
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
    Iat A; Loschi M; Benachour S; Calleja A; Chiche E; Sudaka I; Aquaronne D; Ferrero C; Fenwarth L; Marceau A; Fournier E; Dadone-Montaudie B; Cluzeau T
    Cancer Med; 2024 Mar; 13(6):e7103. PubMed ID: 38506267
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical analysis of allogeneic hematopoietic stem cell transplantation for seven cases of acute myeloid leukemia with BCR::ABL1 fusion].
    Hao MZ; Zhao XL; Zhang XY; Shi YY; Gong M; Zhang LN; Chen SL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):995-1000. PubMed ID: 38503522
    [No Abstract]    [Full Text] [Related]  

  • 6. [The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].
    Zhang WW; Zhang YL; Ren CC; Wu TK; Liu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):176-183. PubMed ID: 38387918
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clinical Significance of Genetic and Molecular Changes in Primary Myeloid Sarcoma].
    Jiang YJ; Zhang CF; Wang HX; Zhao L; Zhang FF; Han XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):27-32. PubMed ID: 38387895
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.
    Paterno G; Palmieri R; Tesei C; Nunzi A; Ranucci G; Mallegni F; Moretti F; Meddi E; Tiravanti I; Marinoni M; Page C; Fagiolo S; Buzzatti E; Secchi R; Gurnari C; Maurillo L; Buccisano F; Venditti A; Del Principe MI
    Thromb Res; 2024 Apr; 236():30-36. PubMed ID: 38387301
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis.
    Wang LY; Li Y; Jiang Q; Jiang H; Wang Y; Xu LP; Zhang XH; Liu KY; Tang FF
    Hematol Oncol; 2024 Mar; 42(2):e3256. PubMed ID: 38367260
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Endogenous retroviruses Suppressyn and Syncytin-2 as innovative prognostic biomarkers in Acute Myeloid leukemia.
    Shen J; Wen X; Xing X; Fozza C; Sechi LA
    Front Cell Infect Microbiol; 2023; 13():1339673. PubMed ID: 38274728
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk npm1-mutated AML.
    Chan O; Al Ali N; Tashkandi H; Ellis A; Ball S; Grenet J; Hana C; Deutsch Y; Zhang L; Hussaini M; Song J; Yun S; Talati C; Kuykendall A; Padron E; Walker A; Roboz G; Desai P; Sallman D; Sweet K; Komrokji R; Lancet J
    Blood Adv; 2024 Mar; 8(5):1075-1083. PubMed ID: 38170740
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The ferroptosis landscape in acute myeloid leukemia.
    Ma Z; Ye W; Huang X; Li X; Li F; Lin X; Hu C; Wang J; Jin J; Zhu B; Huang J
    Aging (Albany NY); 2023 Nov; 15(22):13486-13503. PubMed ID: 38032290
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia.
    Yu T; Zhan Q; Yan X; Luo X; Wang X; Tang X; Zhang H; Yang Z; Chen J; Liu L; Wang L
    Cancer Biol Ther; 2023 Dec; 24(1):2285801. PubMed ID: 38031921
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Detection of npm1 Mutations in Acute Myeloid leukemia by using Drop-Off Droplet Digital PCR and its Clinical Application.
    Jin Y; Xu ZJ; Yu D; Xia PH; Yao DM; Yuan Q; Li T; Xiang HL; Ma JC; Wen XM; Lin J; Qian J
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948486
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MLPA in the initial genetic screening of patients with acute myeloid leukemia.
    Yahya D; Hachmeriyan M; Ruseva T; Chervenkov T; Micheva I
    Rom J Intern Med; 2024 Mar; 62(1):44-51. PubMed ID: 37948316
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
    Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
    Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Blasts with folded nuclei: A histopathologic finding in myeloid leukemia cutis with npm1 and FLT3 mutations.
    Han S; Patel T; Garcia ML; Tirado M
    J Cutan Pathol; 2024 Feb; 51(2):130-134. PubMed ID: 37866827
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia.
    Huang W; Zheng S; Wang Q; Zhao N; Long Z
    Sci Rep; 2023 Sep; 13(1):15658. PubMed ID: 37730831
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Characteristics of genetic variants in 134 patients with Acute myeloid leukemia].
    He M; Zhao X; Tian H; Zhang S; Zhao F; Zhang X; Wu T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Oct; 40(10):1222-1227. PubMed ID: 37730221
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic impact of FLT3-ITD mutation on npm1
    Pan X; Chang Y; Ruan G; Wei F; Jiang H; Jiang Q; Huang X; Zhao X
    Br J Haematol; 2023 Oct; 203(2):212-223. PubMed ID: 37621257
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 27.